5AM Partners V, LLC's Net Worth
$35.5 Million
Who is 5AM Partners V, LLC?
5AM Partners V, LLC has an estimated net worth of $35.5 Million. This is based on reported shares across multiple companies, which include Entrada Therapeutics, Inc., Rallybio Corp, IMPEL NEUROPHARMA INC, Cabaletta Bio, Inc., and Akouos, Inc..
SEC CIK
5AM Partners V, LLC's CIK is 0001791889
Past Insider Trading and Trends
2021 was 5AM Partners V, LLC's most active year for acquiring shares with 14 total transactions. 5AM Partners V, LLC's most active month to acquire stocks was the month of March. 2021 was 5AM Partners V, LLC's most active year for disposing of shares, totalling 17 transactions. 5AM Partners V, LLC's most active month to dispose stocks was the month of October. 2021 saw 5AM Partners V, LLC paying a total of $22,994,661.50 for 8,937,198.28 shares, this is the most they've acquired in one year. In 2020 5AM Partners V, LLC cashed out on 91,627,818 shares for a total of $12,855,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $13.67
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +104.09% | 4.08M |
$20.00 |
—
| 7.99M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rallybio Corp (RLYB) Snapshot price: $1.68
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.03% | -100.00K |
$8.20 | -$820,000.00 | 2.38M |
Mar 7
| |||
Form 4
| -3.87% | -150.00K |
$12.50 | -$1,875,000.00 | 3.73M |
Jun 3
| |||
Form 4
| -2.51% | -100.00K |
$13.00 | -$1,300,000.00 | 3.88M |
May 23
| |||
Form 4
| -5.01% | -210.00K |
$13.05 | -$2,740,500.00 | 3.98M |
Feb 8
| |||
Form 4
| +77.83% | 615.38K |
$13.00 | $7,999,992.00 | 1.41M |
Aug 2
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPEL NEUROPHARMA INC (IMPL) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.88M |
$14.25 | $8,625,000.00 | 2.88M |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cabaletta Bio, Inc. (CABA) Snapshot price: $23.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.50% | -295.00K |
$13.00 | -$3,835,000.00 | 2.06M |
Nov 1
| |||
Form 4
| -23.90% | -625.00K |
$9.70 | -$6,062,500.00 | 1.99M |
Sep 7
| |||
Form 4
| -6.01% | -387.00K |
$13.00 | -$5,031,000.00 | 6.05M |
Jan 8 - Jan 12
| |||
Form 4
| -8.12% | -298.00K |
$14.75 | -$4,395,500.00 | 3.37M |
Dec 10
| |||
Form 4
|
∞
| 3.67M |
$11.00 | $4,999,995.00 | 3.67M |
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akouos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.14M |
—
|
—
|
0
|
Nov 30
| |||
Form 4
| -10.20% | -470.00K |
$18.00 | -$8,460,000.00 | 4.14M |
Dec 29
| |||
Form 4
|
∞
| 4.61M |
$17.00 |
—
| 4.61M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||